Skip To Main Content
COSS Klinikum Stuttgart on Muck Rack

COSS Klinikum Stuttgart

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with COSS Klinikum

Contact COSS Klinikum, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

|
By Sigbjørn Smeland, Stefan Bielack, COSS Klinikum Stuttgart, Jeremy Whelan
| European Journal of Cancer Verified
1. Introduction Osteosarcoma is a malignant bone tumour mainly affecting children and young adults. Although osteosarcoma is the most common primary malignant bone cancer, it is a rare disease and has an annual incidence of 3–4 patients per million. The introduction of multi-agent chemotherapy several decades ago improved 5-year event-free survival in localised high-grade osteosarcoma from less than 20% to around 60%.
Open in Who Shared Issue with article?
See all 1 articles